Arcus Capital Partners, LLC Baxter International Inc Transaction History

Arcus Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$37.58 - $52.57 $219,166 - $306,588	5,832 Added 996.92%	6,417 $260,000
Q4 2022 Jan 27, 2023	SELL	$49.7 - $57.71 $300,834 - $349,318	-6,053 Reduced 91.19%	585 $0
Q3 2022 Oct 25, 2022	BUY	$53.86 - $66.8 $135,996 - $168,670	2,525 Added 61.39%	6,638 $358,000
Q2 2022 Jul 29, 2022	BUY	$63.83 - $80.0 $765 - $960	12 Added 0.29%	4,113 $264,000
Q1 2022 May 04, 2022	BUY	$76.85 - $89.45 $537 - $626	7 Added 0.17%	4,101 $318,000
Q4 2021 Jan 28, 2022	BUY	$74.57 - $87.19 $305,289 - $356,955	4,094 New	4,094 $351,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Arcus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Arcus Capital Partners, LLC with notifications on news.